All cancer types
Results
Phase 1
This trial looked at a new drug called NUC-1031. It was for people with a solid tumour that had spread to other parts of the body (advanced cancer). And who had completed all their .
A solid tumour is any type of cancer apart from or .
Recruitment start: 1 October 2012
Recruitment end: 30 June 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sarah Blagden
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Imperial College London
National Institute for Health Research (NIHR)
NuCana Biomed Ltd
Oxford Cancer Research Centre
Oxford University Hospitals NHS Trust
University of Oxford
Last reviewed: 26 June 2018
CRUK internal database number: 10708